Trial · NCT03333928
Participant flow27
How many started, completed or left each group, period by period.
1 to 20 of 27
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Initial Dosing Period (Period 1) | STARTED | 500mg HTD1801 BID | 16 | |
| Initial Dosing Period (Period 1) | STARTED | 1000 mg HTD1801 BID | 25 | |
| Initial Dosing Period (Period 1) | STARTED | Placebo BID | 18 | |
| Initial Dosing Period (Period 1) | COMPLETED | 500mg HTD1801 BID | 15 | |
| Initial Dosing Period (Period 1) | COMPLETED | 1000 mg HTD1801 BID | 21 | |
| Initial Dosing Period (Period 1) | COMPLETED | Placebo BID | 14 | |
| Initial Dosing Period (Period 1) | NOT COMPLETED | 500mg HTD1801 BID | 1 | |
| Initial Dosing Period (Period 1) | NOT COMPLETED | 1000 mg HTD1801 BID | 4 | |
| Initial Dosing Period (Period 1) | NOT COMPLETED | Placebo BID | 4 | |
| Dose-controlled Extension (Period 2) | STARTED | 500mg HTD1801 BID | 22 | |
| Dose-controlled Extension (Period 2) | STARTED | 1000 mg HTD1801 BID | 29 | |
| Dose-controlled Extension (Period 2) | STARTED | Placebo BID | 0 | |
| Dose-controlled Extension (Period 2) | COMPLETED | 500mg HTD1801 BID | 19 | |
| Dose-controlled Extension (Period 2) | COMPLETED | 1000 mg HTD1801 BID | 28 | |
| Dose-controlled Extension (Period 2) | COMPLETED | Placebo BID | 0 | |
| Dose-controlled Extension (Period 2) | NOT COMPLETED | 500mg HTD1801 BID | 3 | |
| Dose-controlled Extension (Period 2) | NOT COMPLETED | 1000 mg HTD1801 BID | 1 | |
| Dose-controlled Extension (Period 2) | NOT COMPLETED | Placebo BID | 0 | |
| Randomized Withdrawal (Period 3) | STARTED | 500mg HTD1801 BID | 10 | |
| Randomized Withdrawal (Period 3) | STARTED | 1000 mg HTD1801 BID | 14 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03333928/flow